Bourhis, J., Bouko, Y., Koscielny, S., Bakkus, M., Greinix, H., Derigs, G., . . . Goldschmidt, H. (2007). Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: Long term follow-up of an EBMT phase III randomized study. Haematologica, the hematology journal, 92(8), . https://doi.org/10.3324/haematol.10535
Chicago-Zitierstil (17. Ausg.)Bourhis, Jean-Henri, et al. "Relapse Risk After Autologous Transplantation in Patients with Newly Diagnosed Myeloma Is Not Related with Infused Tumor Cell Load and the Outcome Is Not Improved by CD34+ Cell Selection: Long Term Follow-up of an EBMT Phase III Randomized Study." Haematologica, the Hematology Journal 92, no. 8 (2007). https://doi.org/10.3324/haematol.10535.
MLA-Zitierstil (9. Ausg.)Bourhis, Jean-Henri, et al. "Relapse Risk After Autologous Transplantation in Patients with Newly Diagnosed Myeloma Is Not Related with Infused Tumor Cell Load and the Outcome Is Not Improved by CD34+ Cell Selection: Long Term Follow-up of an EBMT Phase III Randomized Study." Haematologica, the Hematology Journal, vol. 92, no. 8, 2007, https://doi.org/10.3324/haematol.10535.